Coronavirus 2019-2020 thread (no unsubstantiated rumours!)
- Thread starter localizer
- Start date
What happened to the narrative that China hacked vaccine data? Did the narrative die out, because they realized it wasn't going to be an effective narrative?
Both the US and EU just said that the UK is cutting corners on the review. Understandably, Boris Johnson is desperate to jumpstart the economy before the Brexit. EU and the US review probably would be more prudent. However, the clinical trials are conducted in just a few months period. Therefore, there just aren't enough data to analyze and give conclusion if any long term side effects existed or if the long term efficacy rate stayed the same.
Furthermore, it is not out of question that companies would manipulate their results and regulators that under tremendous pressure would force to approve vaccines prematurely. For example, Oxford vaccine manipulates the efficacy rate but only come clean til asked by investors. At the moment, they have not released the statistic on each age group so we have no idea what are the efficacy rate for elderly.
Frankly, I think it is wise to wait at least a few months to even consider of taking the vaccine. Let just say those experts have been wrong about masks and asymptomatic transmission. Their assurance isn't base upon science but faith in the system.
However, I do hope that multiple vaccines would work as they are intended. I can't wait for the pandemic to end. It is just that I would rather buckle down at home for a few more months than being a guinea pig. If you are 65 years old or above, then of course you might want to rate the risks and the benefits of taking the vaccine more carefully.
Furthermore, it is not out of question that companies would manipulate their results and regulators that under tremendous pressure would force to approve vaccines prematurely. For example, Oxford vaccine manipulates the efficacy rate but only come clean til asked by investors. At the moment, they have not released the statistic on each age group so we have no idea what are the efficacy rate for elderly.
Frankly, I think it is wise to wait at least a few months to even consider of taking the vaccine. Let just say those experts have been wrong about masks and asymptomatic transmission. Their assurance isn't base upon science but faith in the system.
However, I do hope that multiple vaccines would work as they are intended. I can't wait for the pandemic to end. It is just that I would rather buckle down at home for a few more months than being a guinea pig. If you are 65 years old or above, then of course you might want to rate the risks and the benefits of taking the vaccine more carefully.
Higher doses of the vaccine will work better.
Look like Sinovac clinical trial data has been submitted to analyze before releasing to the public.
Chinese vaccines progress steadily as more nations mull mass inoculation
As more countries, including the UK, Japan and Russia, are eager to roll out mass vaccination programs to combat the deadly coronavirus, China stressed a scientific and diversified pathway to mass vaccination that can satisfy global criteria.
Chinese-developed vaccines report steady progress domestically, while also hearing good news from outside partners. Turkey on Thursday announced a vaccination plan with China's inactivated vaccine later this month, with the first shipment of the Chinese vaccines arriving in Turkey after December 11.
China's fifth vaccine entering Phase III trials - recombinant subunit vaccine - has started recruiting 29,000 volunteers worldwide to the trials in China, Uzbekistan, Indonesia, Pakistan, and Ecuador, the Chinese Academy of Sciences announced on Thursday.
The Global Times learned from the co-developer of the vaccine, Anhui Zhifei Longcom Biopharmaceutical, that the multi-centered trial aims to test some indicators designed in the trials at home, while others are best verified overseas. The bridging experiments linking the domestic and overseas ones are valued for the scientific marketing of vaccine.
So far, 14 diverse Chinese vaccines using five different technology methods are in clinical trials, and five vaccines are undergoing Phase III trials.
East China's Jiangsu Province announced on Thursday it would start vaccine procurement from leading producers, including Sinopharm and Sinovac. It became the latest province to secure its doses after Zhejiang and Sichuan provinces.
Chinese Vice Premier Sun Chunlan stressed a scientific and rigorous preparation for the mass production of the vaccine during an inspection tour of vaccine production lines in Beijing on Wednesday, the same day the UK became the first Western country to approve Pfizer's coronavirus vaccine for mass use.
Sun called for data review and approval work to progress in accordance with strict rules and internationally recognized technical standards.
The visit was seen as a prelude for the vaccine coming to the market following a rigorous and scientific path, despite some countries rushing to mass inoculation to handle new outbreaks that may get worse in winter.
Russia and the UK announced on Wednesday they would start mass vaccinations next week. Japan passed a bill to provide free coronavirus vaccines to every single citizen, with secured offers from US pharmaceutical giants Pfizer and Moderna.
Texas Governor Greg Abbott also announced on Wednesday that the state will receive over 1.4 million doses of the vaccine. It is part of US efforts to begin vaccinating US citizens as early as mid-December, as the pandemic hit the highest daily death toll on Wednesday in six months.
China International Capital Corporation, one of the country's top investment banks, predicted in a report on Thursday that there is a high probability to hear a Chinese-developed vaccine getting official approval before the yearend.
China is very likely to introduce its first officially approved vaccine for mass use in December. It will either be the inactivated vaccine from Sinovac or state-owned Sinopharm, a Beijing-based immunological professor who asked not to be named told the Global Times.
With competitive costs and easier logistics, Chinese-developed vaccines have been favored by some Latin American countries, including Mexico and Brazil.
The Global Times learned from the Sinovac's Brazilian partner Butantan Institute that the data from the vaccine trials across Brazil have been sent to the Brazilian National Health Surveillance Agency. Sinovac told the Global Times that analysis of the clinical data will take some time.
Outside Latin America, Turkey on Thursday announced a vaccination plan starting with Chinese-developed inactivated vaccine later this month, after local trial results revealed zero serious adverse reactions.
Such normal cooperation was tagged by the US media as China's "vaccine diplomacy" to win support in Latin America, which again proved the US is gauging China's generosity with its own mean measure, analysts said.
The US has long seen Latin America as its "backyard," and even though it cannot supply them with vaccines, it does not allow China to do so, Lü Xiang, a research fellow on US studies at the Chinese Academy of Social Sciences, told the Global Times on Thursday.
However, US media's "arms race" discourse is unnecessary as in the next six months global vaccine manufacturers can hardly meet the global demand, given that the pandemic has caused 64.5 million infections worldwide, Lü said. He added that countries with capability should try to produce as many as possible.
It is the US that is in urgent need to boast its success in vaccines because it had lost face for its failure in epidemic control, Lü said.
The expert stressed that if there is a vaccine race, "it is not between China and the US, but a race against time to save lives."
The deadly pandemic has killed nearly 1.5 million people globally so far.
The US can feel free to continue its "America first" strategy, prioritizing domestic needs and supplying its allies, but it should not be narrow-minded and hinder China's cooperation and aid to other countries, the expert said.
Politicizing vaccine issues would harm the vulnerable groups more than others, experts said, noting that the Chinese vaccine would be an ideal choice for places that cannot guarantee quick logistics and ultra-freezing equipments.
Chinese vaccines progress steadily as more nations mull mass inoculation
As more countries, including the UK, Japan and Russia, are eager to roll out mass vaccination programs to combat the deadly coronavirus, China stressed a scientific and diversified pathway to mass vaccination that can satisfy global criteria.
Chinese-developed vaccines report steady progress domestically, while also hearing good news from outside partners. Turkey on Thursday announced a vaccination plan with China's inactivated vaccine later this month, with the first shipment of the Chinese vaccines arriving in Turkey after December 11.
China's fifth vaccine entering Phase III trials - recombinant subunit vaccine - has started recruiting 29,000 volunteers worldwide to the trials in China, Uzbekistan, Indonesia, Pakistan, and Ecuador, the Chinese Academy of Sciences announced on Thursday.
The Global Times learned from the co-developer of the vaccine, Anhui Zhifei Longcom Biopharmaceutical, that the multi-centered trial aims to test some indicators designed in the trials at home, while others are best verified overseas. The bridging experiments linking the domestic and overseas ones are valued for the scientific marketing of vaccine.
So far, 14 diverse Chinese vaccines using five different technology methods are in clinical trials, and five vaccines are undergoing Phase III trials.
East China's Jiangsu Province announced on Thursday it would start vaccine procurement from leading producers, including Sinopharm and Sinovac. It became the latest province to secure its doses after Zhejiang and Sichuan provinces.
Chinese Vice Premier Sun Chunlan stressed a scientific and rigorous preparation for the mass production of the vaccine during an inspection tour of vaccine production lines in Beijing on Wednesday, the same day the UK became the first Western country to approve Pfizer's coronavirus vaccine for mass use.
Sun called for data review and approval work to progress in accordance with strict rules and internationally recognized technical standards.
The visit was seen as a prelude for the vaccine coming to the market following a rigorous and scientific path, despite some countries rushing to mass inoculation to handle new outbreaks that may get worse in winter.
Russia and the UK announced on Wednesday they would start mass vaccinations next week. Japan passed a bill to provide free coronavirus vaccines to every single citizen, with secured offers from US pharmaceutical giants Pfizer and Moderna.
Texas Governor Greg Abbott also announced on Wednesday that the state will receive over 1.4 million doses of the vaccine. It is part of US efforts to begin vaccinating US citizens as early as mid-December, as the pandemic hit the highest daily death toll on Wednesday in six months.
China International Capital Corporation, one of the country's top investment banks, predicted in a report on Thursday that there is a high probability to hear a Chinese-developed vaccine getting official approval before the yearend.
China is very likely to introduce its first officially approved vaccine for mass use in December. It will either be the inactivated vaccine from Sinovac or state-owned Sinopharm, a Beijing-based immunological professor who asked not to be named told the Global Times.
With competitive costs and easier logistics, Chinese-developed vaccines have been favored by some Latin American countries, including Mexico and Brazil.
The Global Times learned from the Sinovac's Brazilian partner Butantan Institute that the data from the vaccine trials across Brazil have been sent to the Brazilian National Health Surveillance Agency. Sinovac told the Global Times that analysis of the clinical data will take some time.
Outside Latin America, Turkey on Thursday announced a vaccination plan starting with Chinese-developed inactivated vaccine later this month, after local trial results revealed zero serious adverse reactions.
Such normal cooperation was tagged by the US media as China's "vaccine diplomacy" to win support in Latin America, which again proved the US is gauging China's generosity with its own mean measure, analysts said.
The US has long seen Latin America as its "backyard," and even though it cannot supply them with vaccines, it does not allow China to do so, Lü Xiang, a research fellow on US studies at the Chinese Academy of Social Sciences, told the Global Times on Thursday.
However, US media's "arms race" discourse is unnecessary as in the next six months global vaccine manufacturers can hardly meet the global demand, given that the pandemic has caused 64.5 million infections worldwide, Lü said. He added that countries with capability should try to produce as many as possible.
It is the US that is in urgent need to boast its success in vaccines because it had lost face for its failure in epidemic control, Lü said.
The expert stressed that if there is a vaccine race, "it is not between China and the US, but a race against time to save lives."
The deadly pandemic has killed nearly 1.5 million people globally so far.
The US can feel free to continue its "America first" strategy, prioritizing domestic needs and supplying its allies, but it should not be narrow-minded and hinder China's cooperation and aid to other countries, the expert said.
Politicizing vaccine issues would harm the vulnerable groups more than others, experts said, noting that the Chinese vaccine would be an ideal choice for places that cannot guarantee quick logistics and ultra-freezing equipments.
It looks like Sinovac would leapfrog Sinopharm to undergo mass vaccination in other countries.
Sao Paulo state gets one million doses of Chinese COVID-19 vaccine
Turkey announces vaccination plan for Chinese CoronaVac
Sao Paulo state gets one million doses of Chinese COVID-19 vaccine
Turkey announces vaccination plan for Chinese CoronaVac
So the UK is approving this US/German vaccine even before US/Germany are approving it.
I heard on radio that the reason why the US was taking longer was because the guy who gives the clearance had been on holiday and needed more time to study the 800page report.
It isn't impossible since they need to schedule the meeting and the place of meeting to go over the data and formally approve the vaccine. As the meeting was scheduled on Dec 10, many experts might feel that they have more time to go over the data. The UK speeding approval gives them a lot of pressure and they need to explain why they take more time than the UK.
Accept China as rising power? US senator saying China been evil threat and stole everything from the West for the last 5000 years...